Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.10te% Regulatory News (SAN)

Share Price Information for Sant Uk.10te% (SAN)

Share Price is delayed by 15 minutes
Get Live Data
164.40    0.00 (0.00%)
Bid:
162.80
Ask:
166.00
Spread: 3.20 (1.966%)
Market Cap: -
SAN Live PriceLast checked at - London Stock Exchange

Intraday Sant Uk.10te% Share Chart

Directorate Change

19 Aug 2015 07:30

RNS Number : 4083W
Santander UK Plc
19 August 2015
 

19 August 2015

SANTANDER UK PLC

BOARD CHANGES

 

Santander UK today announces that Ed Giera has been appointed as an Independent Non-Executive Director and will join the Board with immediate effect. As a result of Bruce Carnegie-Brown's appointment to the Board of Banco Santander, S.A. earlier this year, and therefore no longer being classified as independent in the UK, Ed Giera will assume the Chairmanship of the Santander UK Board Risk Committee on 1 November 2015. Bruce Carnegie-Brown will remain on the Santander UK Board as a Non-Executive Director and a member of the Santander UK Board Risk, Board Remuneration and Board Nomination Committees. 

 

In addition, as a result of nearing the completion of his term of office, Roy Brown has decided to step down as an Independent Non-Executive Director with effect from 31 December 2015. In order to ensure an orderly transition, he will also step down as Chair of Board Remuneration Committee (whilst remaining a member) with effect from 1 September 2015, at which point current Senior Independent Director, Scott Wheway, will assume that role until further notice.

 

- Ends -

 

For media enquiries, please contact:

 

Jennifer Scardino

(Director of Corporate Affairs and Marketing)

020 7756 4886

 

Notes to Editors:

 

Ed Giera CV

 

Ed Giera is an experienced Non-executive Director, having held a number of Board roles since retiring from JP Morgan Securities, the investment banking affiliate of JP Morgan Chase & Co. He is currently a Non-Executive Director at Pension Corporation Group Limited, a holding company for the Pension Insurance Corporation, where he also chairs the Board Audit & Risk Committee. Alongside this role, he is a Non-executive Director for two funds managed by the alternative investment manager, Renshaw Bay LLP. Mr Giera also provided corporate finance advisory and fiduciary services as Principal of E.J. Giera, LLC, and was formerly a Non-Executive Director for NovaTech, L.L.C. and the Life and Longevity Markets Association. 

 

Additional information about Santander UK and Banco Santander, S.A.

Banco Santander (SAN.MC, STD.N, BNC.LN) ('Santander') is a retail and commercial bank, based in Spain, with a presence in 10 main markets. Santander is the largest bank in the eurozone by market capitalisation. Founded in 1857, Santander had EUR 1.43 trillion in managed funds, 117 million customers, 12,951 branches - more than any other international bank - and 185,405 employees at 31 December 2014. It is the largest financial group in Spain and Latin America. It also has significant positions in the United Kingdom, Portugal, Germany, Poland and the northeast United States. In the year ended 2014, Santander registered EUR 5.816 billion in attributable profit, an increase of 39% from the same period of the previous year.

 

Santander UK is a financial services provider in the UK that offers a wide range of personal and commercial financial products and services. The bank serves more than 14 million active customers with 20,500 employees and operates through 900 branches and 68 regional Corporate Business Centres.

 

Banco Santander, S.A. has a standard listing of its ordinary shares on the London Stock Exchange and Santander UK plc continues to have its preference shares listed on the London Stock Exchange. Nothing in this announcement constitutes or should be construed as constituting a profit forecast.

 

Further information about Santander UK is available at the group's website: www.aboutsantander.co.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALLFFETIITLIE
Date   Source Headline
17th Aug 20181:17 pmRNSForm 8.3 - Shire plc
17th Aug 20181:16 pmRNSForm 8.3 - Shire plc
17th Aug 20181:15 pmRNSForm 8.3 - Shire plc
14th Aug 20181:47 pmRNSPublication of Final Terms
10th Aug 20185:28 pmRNSPublication of Suppl.Prospcts
10th Aug 20187:15 amRNSHalf-year Report
10th Aug 20187:15 amRNSHalf-year Report
25th Jul 20182:24 pmRNSPublication of Suppl.Prospcts
25th Jul 20182:16 pmRNSPublication of Suppl.Prospcts
25th Jul 20187:15 amRNSQuarterly Management Statement - 30 June 2018
9th Jul 20184:24 pmRNSArticle 8
9th Jul 201812:02 pmRNSNotice of Delisting
25th Jun 201812:31 pmRNSPublication of Suppl.Prospcts
25th Jun 201812:26 pmRNSPublication of Suppl.Prospcts
13th Jun 201810:47 amRNSApproval of Ring-Fencing Transfer Scheme
31st May 201810:53 amRNSDirectorate Change
14th May 20182:24 pmRNSArticle 8
14th May 201811:29 amRNSNotice of Delisting - Series 1125
8th May 20184:21 pmRNSPublication of Final Terms
8th May 20183:26 pmRNSPublication of Final Terms
4th May 201812:41 pmRNSPublication of Final Terms
27th Apr 20184:47 pmRNSStatement re Change of Paying & Transfer Agent
27th Apr 201811:46 amRNSNotice Change of Agent
24th Apr 20186:15 pmRNSPublication of a Prospectus
24th Apr 20182:36 pmRNSPublication of Suppl.Prospcts
24th Apr 20187:15 amRNS1st Quarter Results
13th Apr 20182:16 pmRNSPublication of Final Terms
11th Apr 20184:49 pmRNSOffer period extension Series 1125-1126
29th Mar 201811:29 amRNSArticle 8
28th Mar 20185:11 pmRNSPublication of Final Terms
26th Mar 20184:27 pmRNSArticle 8
19th Mar 20182:29 pmRNSDelisting notice - Series 1121 - XS1710683985
19th Mar 201811:52 amRNSArticle 8
12th Mar 201810:40 amRNSCall notice XS0907246812. Series 790
9th Mar 20183:46 pmRNSPublication of Final Terms
2nd Mar 20184:31 pmRNSPre-Stab: Santander, GBP 50m Tap, due 27/02/2020
2nd Mar 20184:14 pmRNSPublication of Suppl.Prospcts
2nd Mar 20184:10 pmRNSPublication of Suppl.Prospcts
2nd Mar 20184:02 pmRNSPublication of Final Terms
2nd Mar 20183:58 pmRNSPublication of Final Terms
28th Feb 201812:45 pmRNSAnnual Financial Report
28th Feb 201812:40 pmRNSAnnual Financial Report
26th Feb 20185:20 pmRNSPublication of Final Terms
23rd Feb 20182:47 pmRNSArticle 8
22nd Feb 20185:34 pmRNSPre-Stab Notice - SANUK, GBP 250m, due 27/02/2020
12th Feb 201810:58 amRNSNotice of Early Redemption
7th Feb 20185:43 pmRNSPublication of Suppl.Prospcts
7th Feb 20185:39 pmRNSPublication of Suppl.Prospcts
6th Feb 201811:41 amRNSUpdate on Ring-fencing & Part VII Transfer Scheme
31st Jan 20187:15 amRNSQ4 17 - Quarterly Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.